Flanvotumab
Flanvotumab (IMC-20D7S) is a humanized monoclonal antibody targeting tyrosinase-related protein (TYRP1), exhibiting potent antitumor activity through natural killer-mediated and antibody-dependent cell-mediated cytotoxicity (ADCC) .
Product Specifications
CAS Number
1188277-05-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Tyrosinase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15150441 1 Vial
Lentiviral mouse Fam98c shRNA (UAS) - Lentiviral mouse Fam98c shRNA (UAS, GFP) (100)
Ask
View Details 
MBS1207618-01 0.02 mg (E-Coli)
Recombinant Acinetobacter baumannii Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details 
MBS1207618-02 0.1 mg (E-Coli)
Recombinant Acinetobacter baumannii Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details MBS1207618-03 0.02 mg (Yeast)
Recombinant Acinetobacter baumannii Phosphoribosylaminoimidazole-succinocarboxamide synthase (purC)
Ask
View Details